These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24275302)

  • 21. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outpatient management of pediatric heart failure.
    O'Connor MJ; Rosenthal DN; Shaddy RE
    Heart Fail Clin; 2010 Oct; 6(4):515-29, ix. PubMed ID: 20869651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S
    Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Control of blood pressure in prevention of hypertensive end-organ damage].
    Kido M; Ando K; Fujita T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():389-93. PubMed ID: 15171405
    [No Abstract]   [Full Text] [Related]  

  • 25. Heart failure: an overview of consensus guidelines and nursing implications.
    Svendsen A
    Can J Cardiovasc Nurs; 2003; 13(2):30-4. PubMed ID: 12802836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment and risk in heart failure: gaps in evidence or quality?
    Peterson PN; Rumsfeld JS; Liang L; Hernandez AF; Peterson ED; Fonarow GC; Masoudi FA;
    Circ Cardiovasc Qual Outcomes; 2010 May; 3(3):309-15. PubMed ID: 20388872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slowing the progression of CHF. Drug therapy to correct neurohormonal abnormalities.
    Ward RP; Anderson AS
    Postgrad Med; 2001 Mar; 109(3):36-8, 41-5. PubMed ID: 11265361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical inquiries. What is the most effective beta-blocker for heart failure?
    Neher JO; Safranek S; Grover F
    J Fam Pract; 2003 May; 52(5):396, 398-9. PubMed ID: 12737773
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of ACCF/AHA Stage C heart failure.
    Adigopula S; Vivo RP; DePasquale EC; Nsair A; Deng MC
    Cardiol Clin; 2014 Feb; 32(1):73-93, viii. PubMed ID: 24286580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
    MMW Fortschr Med; 2004 Oct; 146(43):58-9. PubMed ID: 15559524
    [No Abstract]   [Full Text] [Related]  

  • 31. Current pharmacologic management of pediatric heart failure in congenital heart disease.
    Bautista-Hernandez V; Sanchez-Andres A; Portela F; Fynn-Thompson F
    Curr Vasc Pharmacol; 2011 Sep; 9(5):619-28. PubMed ID: 21314633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congestive heart failure in pediatric patients.
    Kay JD; Colan SD; Graham TP
    Am Heart J; 2001 Nov; 142(5):923-8. PubMed ID: 11685182
    [No Abstract]   [Full Text] [Related]  

  • 33. [Management of heart failure].
    Jourdain P
    Soins; 2013 Apr; (774):29-34. PubMed ID: 23697056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.
    Maggioni AP; Anker SD; Dahlström U; Filippatos G; Ponikowski P; Zannad F; Amir O; Chioncel O; Leiro MC; Drozdz J; Erglis A; Fazlibegovic E; Fonseca C; Fruhwald F; Gatzov P; Goncalvesova E; Hassanein M; Hradec J; Kavoliuniene A; Lainscak M; Logeart D; Merkely B; Metra M; Persson H; Seferovic P; Temizhan A; Tousoulis D; Tavazzi L;
    Eur J Heart Fail; 2013 Oct; 15(10):1173-84. PubMed ID: 23978433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heart failure after acute myocardial infarct. Early aldosterone blockade increases survival rate].
    MMW Fortschr Med; 2005 Jul; 147(27-28):44. PubMed ID: 16041942
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence-based therapy for heart failure.
    Deedwania PC; Carbajal E
    Med Clin North Am; 2012 Sep; 96(5):915-31. PubMed ID: 22980055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
    Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hypertension in patients with heart failure].
    Takekoshi N; Asaji T; Tada N
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():478-83. PubMed ID: 15171419
    [No Abstract]   [Full Text] [Related]  

  • 39. How well are chronic heart failure patients being managed?
    Fonarow GC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.